Ahmed Ridwan Oladotun, Sewram Vikash, Oyesegun Adisa Rasaaq, Ayele Birhanu, van Wyk Abrie, Fernandez Pedro
African Cancer Institute, Department of Global Health, Stellenbosch University, PO Box 241, Tygerberg, 8000 South Africa.
Department of Radiotherapy and Oncology, National Hospital, Plot 132, Central District (Phase II), P.M.B 425, Garki, Abuja, Nigeria.
Afr J Urol. 2022;28(1):6. doi: 10.1186/s12301-022-00273-y. Epub 2022 Mar 5.
Globally, prostate cancer (PCa) is the commonest non-cutaneous male malignancy. It is more aggressive among black men with little known reasons as to the cause and continued trend among black men. This disproportionate pattern of PCa especially among black men of African ancestry resident in Africa calls for a closer look. Nigeria and South Africa, combined, have the highest cumulative risk incidence of PCa in Africa. The present study investigated the clinicopathologic behaviour of PCa among Nigerian and South African black men and the relationship between the disease and socio-demographic characteristics alongside medical co-morbidities.
A retrospective cross-sectional study was undertaken in which de-identified records of 234 black men with pathologically confirmed PCa between 2007 and 2017 from two tertiary hospitals, in Nigeria (National Hospital, Abuja) and South Africa (Tygerberg Hospital, Cape Town), were reviewed.
Median age at presentation from both countries was 66 years (interquartile range, IQR 61-73 years) while the median PSA at presentation was 46 ng/ml (IQR 16-336.5 ng/ml). Half of the men (117/234) presented with locally advanced disease while metastatic disease was observed in 65.9% (27/41) of Nigerian men and 34.1% (14/41) of South African men. Thirty-three per cent of the men presented with organ-confined disease. Overall, Nigerian men presented with less organ-confined disease and significantly higher stage of disease ( < 0.001). Risk stratification using PSA, Gleason scores and T-staging showed that 84.2% ( = 197) of all the men presented with high-risk PCa disease. There was a statistically significant difference between Nigerian and South African black men ( = 0.003) in terms of disease risk at presentation. Logistic regression analysis showed that age (Adjusted OR 1.053 (95% CI 1.003-1.106), = 0.003) and country of residence (Adjusted OR 4.281 (95% CI 1.690-10.844), = 0.002) had a statistically significant relationship with high risk of PCa while disease co-morbidities (like diabetes and hypertension) and rural/urban location in both countries did not.
Disparities exist between PCa presentation and clinicopathologic behaviour among Nigerian and South African black men. Nigerian men showed higher disease risk at presentation. Environmental-genetic interactions need further exploration in the aetio-pathogenesis of PCa in black men of African ancestry.
在全球范围内,前列腺癌(PCa)是最常见的非皮肤性男性恶性肿瘤。在黑人男性中,其侵袭性更强,而关于病因及黑人男性中持续存在的发病趋势,人们知之甚少。PCa这种不成比例的发病模式,尤其是在居住在非洲的非洲裔黑人男性中,值得深入研究。尼日利亚和南非合计在非洲拥有最高的PCa累积风险发病率。本研究调查了尼日利亚和南非黑人男性中PCa的临床病理行为,以及该疾病与社会人口学特征和合并症之间的关系。
进行了一项回顾性横断面研究,对2007年至2017年间来自尼日利亚(阿布贾国家医院)和南非(开普敦泰格堡医院)两家三级医院的234名经病理确诊为PCa的黑人男性的匿名记录进行了审查。
两国患者就诊时的中位年龄为66岁(四分位间距,IQR 61 - 73岁),而就诊时的中位前列腺特异性抗原(PSA)为46 ng/ml(IQR 16 - 336.5 ng/ml)。一半的男性(117/234)表现为局部晚期疾病,而在尼日利亚男性中有65.9%(27/41)、南非男性中有34.1%(14/41)观察到转移性疾病。33%的男性表现为器官局限性疾病。总体而言,尼日利亚男性表现出器官局限性疾病较少,疾病分期显著更高(<0.001)。使用PSA、 Gleason评分和T分期进行风险分层显示,所有男性中有84.2%(=197)表现为高危PCa疾病。在就诊时的疾病风险方面,尼日利亚和南非黑人男性之间存在统计学显著差异(=0.003)。逻辑回归分析表明,年龄(调整后的比值比1.053(95%置信区间1.003 - 1.106),=0.003)和居住国家(调整后的比值比4.281(95%置信区间1.690 - 10.844),=0.002)与PCa的高风险存在统计学显著关系,而两国的疾病合并症(如糖尿病和高血压)以及农村/城市居住地则没有这种关系。
尼日利亚和南非黑人男性在PCa的表现和临床病理行为方面存在差异。尼日利亚男性在就诊时显示出更高的疾病风险。在非洲裔黑人男性PCa的病因发病机制中,环境 - 基因相互作用需要进一步探索。